Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Week in Review

Summaries of each week's events in China biotech are provided free to all readers.  A weekly email newsletter providing direct links to these articles is also available - click here for free email newsletter...

Week in Review: China Life Science Starts off 2019 with $425 Million in Deals
Week in Review: 2018 Results: China Life Science Investment Hits Record Levels
Week in Review: Shanghai Industrial to Start $7.3 Billion Biomedical Fund in 2019
Week in Review: $1.5 Billion in China Deals with One Week Left in 2018
Week in Review: Two China Biopharmas Raise $1.4 Billion in Hong Kong IPOs
Upcoming event
Shanghai , China
May 8-9, 2019
 
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China